These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 36430497)
21. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease. Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865 [TBL] [Abstract][Full Text] [Related]
22. Mitochondrial dysfunction in genetic animal models of Parkinson's disease. Trancikova A; Tsika E; Moore DJ Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447 [TBL] [Abstract][Full Text] [Related]
23. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease. Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085 [TBL] [Abstract][Full Text] [Related]
24. PINK1 protein in normal human brain and Parkinson's disease. Gandhi S; Muqit MM; Stanyer L; Healy DG; Abou-Sleiman PM; Hargreaves I; Heales S; Ganguly M; Parsons L; Lees AJ; Latchman DS; Holton JL; Wood NW; Revesz T Brain; 2006 Jul; 129(Pt 7):1720-31. PubMed ID: 16702191 [TBL] [Abstract][Full Text] [Related]
25. Down-regulation of B cell-related genes in peripheral blood leukocytes of Parkinson's disease patients with and without GBA mutations. Kobo H; Bar-Shira A; Dahary D; Gan-Or Z; Mirelman A; Goldstein O; Giladi N; Orr-Urtreger A Mol Genet Metab; 2016 Feb; 117(2):179-85. PubMed ID: 26410072 [TBL] [Abstract][Full Text] [Related]
26. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease. Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353 [TBL] [Abstract][Full Text] [Related]
27. Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease. Sircar E; Rai SR; Wilson MA; Schlossmacher MG; Sengupta R Arch Biochem Biophys; 2021 Jun; 704():108869. PubMed ID: 33819447 [TBL] [Abstract][Full Text] [Related]
28. Targeting α-synuclein post-translational modifications in Parkinson's disease. Canever JB; Soares ES; de Avelar NCP; Cimarosti HI Behav Brain Res; 2023 Feb; 439():114204. PubMed ID: 36372243 [TBL] [Abstract][Full Text] [Related]
29. Detection of copy number changes in genes associated with Parkinson's disease in Iranian patients. Darvish H; Movafagh A; Omrani MD; Firouzabadi SG; Azargashb E; Jamshidi J; Khaligh A; Haghnejad L; Naeini NS; Talebi A; Heidari-Rostami HR; Noorollahi-Moghaddam H; Karkheiran S; Shahidi GA; Paknejad SM; Ashrafian H; Abdi S; Kayyal M; Akbari M; Pedram N; Emamalizadeh B Neurosci Lett; 2013 Sep; 551():75-8. PubMed ID: 23880019 [TBL] [Abstract][Full Text] [Related]
30. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease. Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973 [TBL] [Abstract][Full Text] [Related]
31. Molecular chaperones and Parkinson's disease. Hu S; Tan J; Qin L; Lv L; Yan W; Zhang H; Tang B; Wang C Neurobiol Dis; 2021 Dec; 160():105527. PubMed ID: 34626793 [TBL] [Abstract][Full Text] [Related]
32. LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies. Dzamko N; Gysbers AM; Bandopadhyay R; Bolliger MF; Uchino A; Zhao Y; Takao M; Wauters S; van de Berg WD; Takahashi-Fujigasaki J; Nichols RJ; Holton JL; Murayama S; Halliday GM Mov Disord; 2017 Mar; 32(3):423-432. PubMed ID: 27911006 [TBL] [Abstract][Full Text] [Related]
33. SWATH Mass Spectrometry-Based CSF Proteome Profile of Zafar S; Noor A; Younas N; Shafiq M; Schmitz M; Wurster I; Brockmann K; Gasser T; Zerr I Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430645 [TBL] [Abstract][Full Text] [Related]
34. Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment. Gomez A; Ferrer I Acta Neuropathol; 2010 Aug; 120(2):155-67. PubMed ID: 20232069 [TBL] [Abstract][Full Text] [Related]
35. Mitophagy, a Form of Selective Autophagy, Plays an Essential Role in Mitochondrial Dynamics of Parkinson's Disease. Wang XL; Feng ST; Wang YT; Yuan YH; Li ZP; Chen NH; Wang ZZ; Zhang Y Cell Mol Neurobiol; 2022 Jul; 42(5):1321-1339. PubMed ID: 33528716 [TBL] [Abstract][Full Text] [Related]
37. Neurochemistry changes associated with mutations in familial Parkinson's disease. Siddique MM; Tan EK Curr Med Chem; 2010; 17(35):4378-91. PubMed ID: 20939808 [TBL] [Abstract][Full Text] [Related]
38. Mitochondrial-Associated Membranes in Parkinson's Disease. Hattori N; Arano T; Hatano T; Mori A; Imai Y Adv Exp Med Biol; 2017; 997():157-169. PubMed ID: 28815529 [TBL] [Abstract][Full Text] [Related]
39. A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons. Kim GJ; Mo H; Liu H; Wu Z; Chen S; Zheng J; Zhao X; Nucum D; Shortland J; Peng L; Elepano M; Tang B; Olson S; Paras N; Li H; Renslo AR; Arkin MR; Huang B; Lu B; Sirota M; Guo S Elife; 2021 Sep; 10():. PubMed ID: 34550070 [TBL] [Abstract][Full Text] [Related]